Which is more profitable, Bayer or Roche?

Roche keeps more of every sale as profit.

Which grows faster, Bayer or Roche?

Roche grew its sales faster in recent years.

Which is cheaper, Bayer or Roche?

Roche costs less for each unit of yearly profit (lower P/E).

Which has less debt, Bayer or Roche?

Roche would need fewer years of earnings to pay off its debt.

BayerBAYN.DEvs

RocheRO.SW

Bayer vs Roche stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Roche is more profitable, grows faster, is cheaper for its profits and has less debt.

Side by side

	Bayer	Roche
	€55.5 billion	CHF 328 billion
	-7.9%	20.3%
	−3.5%	−1.3%
	No profit yet	25.5×
	15.5 years	1.3 years
	-1.0%	23.2%
	0.2%	2.4%

Open Bayer Open Roche

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Bayer vs Johnson & Johnson · Bayer vs Eli Lilly · Bayer vs Merck & · Roche vs Becton, Dickinson and · Roche vs Bristol-Myers Squibb · Roche vs Boston Scientific · Roche vs CSL